JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on February 8, 2007; DOI: 10.1124/jpet.106.117218


0022-3565/07/3212-656-662$20.00
JPET 321:656-662, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.117218v1
321/2/656    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Urquhart, P.
Right arrow Articles by Perretti, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Urquhart, P.
Right arrow Articles by Perretti, M.

INFLAMMATION, IMMUNOPHARMACOLOGY, AND ASTHMA

Carbon Monoxide-Releasing Molecules Modulate Leukocyte-Endothelial Interactions under Flow

Paula Urquhart, Guglielmo Rosignoli, Dianne Cooper, Roberto Motterlini, and Mauro Perretti

William Harvey Research Institute, London, United Kingdom (P.U., G.R., D.C., M.P.); and Vascular Biology Unit, Department of Surgical Research, Northwick Park Institute for Medical Research Harrow, Middlesex, United Kingdom (R.M.)

Carbon monoxide (CO) generated by the enzyme heme oxygenase during the breakdown of heme is known to mediate a number of biological effects. Here, we investigated whether CO liberated from a water-soluble CO-releasing molecule (CO-RM) is capable of modulating leukocyte-endothelial interactions. Tricarbonylchoro(glycinato)ruthenium (II) (CORM-3), a fast CO releaser, proved to be anti-inflammatory in two distinct models of acute inflammation in vivo. In both cases, a significant reduction in neutrophil extravasation was observed. Subsequent in vitro static experiments showed that CORM-3 produced a direct effect on neutrophil (polymorphonuclear neutrophil; PMN) adhesion molecule expression; dose-dependently inhibiting platelet-activating factor stimulated CD11b up-regulation and L-selectin shedding, whereas no effect was observed on up-regulation of human umbilical vein endothelial cell (HUVEC) adhesion molecules intercellular adhesion molecule-1 or E-selectin nor on interleukin-8 chemokine production. In addition, when PMN interaction with HUVECs was studied, an inhibitory effect of CORM-3 on cell capture and rolling was observed. The effect of CORM-3 on PMN CD11b expression was mimicked by the incubation of PMN with the selective large potassium channel opener 1,3-dihydro-1-(2-hydroxy-5-(trifluoromethyl)-phenyl)-5-(trifluoromethyl)-2H-benzimidazol-2-one (NS-1619), which suggests that CORM-3 actions in this instance are mediated, at least in part, via opening of this channel. In conclusion, we have reported that CORM-3 possesses acute anti-inflammatory effects in vivo and that these are probably the result of targeting PMN activation and rolling upon the endothelium.


Received November 17, 2006; accepted February 6, 2007.

Address correspondence to: Dr. Mauro Perretti, William Harvey Research Institute, Barts and The London, Charterhouse Square, London EC1M 6BQ, UK. E-mail: m.perretti{at}qmul.ac.uk




This article has been cited by other articles:


Home page
Am. J. Respir. Cell Mol. Bio.Home page
L. Zheng, Z. Zhou, L. Lin, S. Alber, S. Watkins, N. Kaminski, A. M. K. Choi, and D. Morse
Carbon Monoxide Modulates {alpha}-Smooth Muscle Actin and Small Proline Rich-1a Expression in Fibrosis
Am. J. Respir. Cell Mol. Biol., July 1, 2009; 41(1): 85 - 92.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
O De Backer, E Elinck, B Blanckaert, L Leybaert, R Motterlini, and R A Lefebvre
Water-soluble CO-releasing molecules reduce the development of postoperative ileus via modulation of MAPK/HO-1 signalling and reduction of oxidative stress
Gut, March 1, 2009; 58(3): 347 - 356.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
M L Ferrandiz, N Maicas, I Garcia-Arnandis, M C Terencio, R Motterlini, I Devesa, L A B Joosten, W B van den Berg, and M J Alcaraz
Treatment with a CO-releasing molecule (CORM-3) reduces joint inflammation and erosion in murine collagen-induced arthritis
Ann Rheum Dis, September 1, 2008; 67(9): 1211 - 1217.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
M. I. Guillen, J. Megias, V. Clerigues, F. Gomar, and M. J. Alcaraz
The CO-releasing molecule CORM-2 is a novel regulator of the inflammatory process in osteoarthritic chondrocytes
Rheumatology, September 1, 2008; 47(9): 1323 - 1328.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. Megias, M. I. Guillen, A. Bru, F. Gomar, and M. J. Alcaraz
The Carbon Monoxide-Releasing Molecule Tricarbonyldichlororuthenium(II) Dimer Protects Human Osteoarthritic Chondrocytes and Cartilage from the Catabolic Actions of Interleukin-1{beta}
J. Pharmacol. Exp. Ther., April 1, 2008; 325(1): 56 - 61.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
D. Morse and A. M. K. Choi
Inhaled CO in the treatment of acute lung injury
Am J Physiol Lung Cell Mol Physiol, April 1, 2008; 294(4): L642 - L643.
[Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
G. Cepinskas, K. Katada, A. Bihari, and R. F. Potter
Carbon monoxide liberated from carbon monoxide-releasing molecule CORM-2 attenuates inflammation in the liver of septic mice
Am J Physiol Gastrointest Liver Physiol, January 1, 2008; 294(1): G184 - G191.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics.